- Home
- ORMP vs TMCI Comparison
ORMP vs TMCI Comparison
Compare ORMP & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | TMCI |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 144.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | TMCI |
|---|---|---|
| Price | $3.35 | $1.86 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.21 |
| AVG Volume (30 Days) | 186.3K | ★ 622.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.62% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.12 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $1.81 |
| 52 Week High | $3.71 | $10.30 |
Technical Indicators
Market Signals| Indicator | ORMP | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 49.80 | 29.74 |
| Support Level | $3.14 | $1.81 |
| Resistance Level | $3.51 | $2.31 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 41.29 | 9.09 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.